Free Trial

Freestone Capital Holdings LLC Grows Position in Cardinal Health, Inc. $CAH

Cardinal Health logo with Medical background

Key Points

  • Freestone Capital Holdings LLC has increased its stake in Cardinal Health, Inc. by 3.5%, owning 57,615 shares worth approximately $7.94 million as of its latest filing.
  • Cardinal Health announced a quarterly dividend of $0.5107 per share, which will be paid on October 15th, indicating a 1.4% dividend yield.
  • Analysts have a consensus rating of "Moderate Buy" for Cardinal Health, with an average price target of $163.20, reflecting optimism over the company's financial performance.
  • Need better tools to track Cardinal Health? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Freestone Capital Holdings LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,615 shares of the company's stock after purchasing an additional 1,971 shares during the period. Freestone Capital Holdings LLC's holdings in Cardinal Health were worth $7,938,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Townsquare Capital LLC boosted its holdings in shares of Cardinal Health by 31.2% during the 4th quarter. Townsquare Capital LLC now owns 4,229 shares of the company's stock valued at $500,000 after acquiring an additional 1,005 shares during the last quarter. Mariner LLC lifted its position in Cardinal Health by 5.4% during the fourth quarter. Mariner LLC now owns 52,160 shares of the company's stock valued at $6,169,000 after purchasing an additional 2,685 shares during the period. CreativeOne Wealth LLC boosted its holdings in Cardinal Health by 10.5% in the fourth quarter. CreativeOne Wealth LLC now owns 4,036 shares of the company's stock worth $477,000 after purchasing an additional 382 shares during the last quarter. United Capital Financial Advisors LLC boosted its holdings in Cardinal Health by 3.3% in the fourth quarter. United Capital Financial Advisors LLC now owns 5,516 shares of the company's stock worth $652,000 after purchasing an additional 174 shares during the last quarter. Finally, NewEdge Advisors LLC grew its position in Cardinal Health by 5.3% in the 4th quarter. NewEdge Advisors LLC now owns 12,429 shares of the company's stock worth $1,470,000 after purchasing an additional 622 shares during the period. 87.17% of the stock is owned by institutional investors.

Analyst Ratings Changes

CAH has been the topic of several research analyst reports. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a report on Tuesday, August 12th. Bank of America raised their target price on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Finally, Evercore ISI dropped their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a report on Wednesday, August 13th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Cardinal Health currently has an average rating of "Moderate Buy" and an average target price of $163.20.

Check Out Our Latest Stock Report on Cardinal Health

Cardinal Health Trading Up 2.4%

CAH traded up $3.6280 during trading on Wednesday, hitting $152.6480. 2,522,918 shares of the company traded hands, compared to its average volume of 2,417,688. The company has a market cap of $36.45 billion, a PE ratio of 23.67, a P/E/G ratio of 1.26 and a beta of 0.67. The stock's 50-day simple moving average is $159.47 and its two-hundred day simple moving average is $144.94. Cardinal Health, Inc. has a 1 year low of $106.54 and a 1 year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the prior year, the firm earned $1.84 EPS. The business's revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio is currently 31.63%.

Insider Buying and Selling

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the transaction, the chief executive officer owned 235,901 shares in the company, valued at $35,125,658.90. This trade represents a 31.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares of the company's stock, valued at $2,298,293.14. The trade was a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 235,775 shares of company stock valued at $35,102,939 in the last three months. Corporate insiders own 0.09% of the company's stock.

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

See Also

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines